Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Annales De Dermatologie Et De Venereologie|December 15, 2012
[Successive cutaneous adverse reactions to nilotinib and imatinib in a single patient]M Lamchahab, M Qachouh, F Hali, et al.
Medical Oncology (Northwood, London, England)|June 11, 2014
Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinibY Kassogue, M Quachouh, H Dehbi, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|April 13, 2013
[Pregnancy in Gaucher disease]H Boufettal, A Quessar, Z Jeddaoui, et al.
Revue Neurologique|October 20, 2009
[Cerebral venous thrombosis and acute polyradiculoneuritis revealing systemic lupus erythematosus]N Ahbeddou, A Benomar, K Rasmouni, et al.
Journal of Medical Case Reports|August 27, 2021
Xeroderma pigmentosum and acute myeloid leukemia: a case reportH Bencharef, M Lamchahab, D Dassouli, et al.
Case Reports in Oncological Medicine|July 21, 2020
Peripheral Medulloepithelioma: A Rare Entity to KnowW Matrane, S Cherkaoui, M Regragui, et al.
Revue D'Epidemiologie Et De Sante Publique|May 10, 2021
[Quality of "crisis communication" media during the COVID-19 pandemic in the Great Maghreb countries]A Ben Abdelaziz, N El Haddad, H Hannachi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 17, 2019
Outcome of Acute Myeloid Leukemia in Children Adolescents and Young Adults Treated with an Uniform Protocol in Casablanca, MoroccoB Housou, S Cherkaoui, M Lamchahab, et al.
Genetics and Molecular Research : GMR|March 3, 2015
Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patientsA Moumen, H Dehbi, D Kottwitz, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot studyP Lehn, A Quessar, A Devergie, et al.
Pageof 3